Fiera Capital Corp Ionis Pharmaceuticals Inc Transaction History

Fiera Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$43.37 - $59.54 $21.3 Million - $29.3 Million	-492,213 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $3.74 Million - $4.68 Million	-87,162 Reduced 15.04%	492,213 $25.4 Million
Q2 2018 Aug 02, 2018	SELL	$40.53 - $50.7 $59,862 - $74,883	-1,477 Reduced 0.25%	579,375 $24.1 Million
Q1 2018 May 11, 2018	SELL	$44.08 - $55.05 $1.23 Million - $1.54 Million	-28,012 Reduced 4.6%	580,852 $25.6 Million
Q4 2017 Feb 09, 2018	SELL	$50.3 - $64.39 $1.08 Million - $1.38 Million	-21,448 Reduced 3.4%	608,864 $30.6 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $28.7 Million - $37.5 Million	630,312	630,312 $32 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.